Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00187
|
|||||
| Drug Name |
Prucalopride
|
|||||
| Synonyms |
0A09IUW5TP; 179474-81-8; 4-Amino-5-chloro-2,3-dihydro-N-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide; 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide; 4-Amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide; 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide; C18H26ClN3O3; CHEMBL117287; Motegrity; Prucalopride [USAN:INN:BAN]; R 093877; R-093877; R0-93877; R093877; UNII-0A09IUW5TP
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic idiopathic constipation [ICD11:ME05.0] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H26ClN3O3
|
|||||
| Canonical SMILES |
COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl
|
|||||
| InChI |
InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)
|
|||||
| InChIKey |
ZPMNHBXQOOVQJL-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 179474-81-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 367.9 | Topological Polar Surface Area | 76.8 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10056110
,103341576
,104015490
,111619007
,124772073
,126522466
,126666797
,126731460
,129936276
,134340386
,135131495
,135650861
,135697691
,136367812
,137009981
,142510835
,143497674
,14803834
,152090515
,152159696
,152234885
,162009741
,162011596
,162205091
,164764612
,170466188
,170502890
,174006285
,174528011
,175438062
,179150084
,185997006
,188899543
,196408592
,198942073
,198993142
,210275056
,210280694
,223379010
,223662148
,226407081
,249734221
,251883665
,251971243
,252151346
,36118680
,50329889
,57353981
,85209596
,96025885
|
|||||
| ChEBI ID |
CHEBI:135552
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Prucalopride was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Resolor, INN-prucalopride | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.